PTEN and breast cancer: Consistent with a critical role of NEDD4 phosphorylation in triggering its degradation, introducing a non-degradable NEDD4 mutant (S347A/S348A) promoted cancer cell growth and migration in both PTEN positive prostate and breast cancer cells (Figure 5).